Abstract
Because stimulant use disorders remain prevalent across the lifespan, cognition is an important area of clinical care and research focus among aging adults with stimulant use disorders. This secondary analysis of a National Institute on Drug Abuse Clinical Trials Network study suggests that decision making, verbal learning/memory, executive function, and set shifting are important cognitive domains to screen clinically and treat in aging adults with stimulant use disorders. Some suggestions are made on how clinical treatment providers can practically use these results. An important direction for future research is the development of cognitively remediating treatments for impaired cognitive domains in aging adults with stimulant use disorders.
Publication types
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Age Factors
-
Amphetamine-Related Disorders / epidemiology*
-
Amphetamine-Related Disorders / psychology
-
Amphetamine-Related Disorders / rehabilitation*
-
Central Nervous System Stimulants*
-
Cocaine-Related Disorders / epidemiology*
-
Cocaine-Related Disorders / psychology
-
Cocaine-Related Disorders / rehabilitation*
-
Cognition Disorders / epidemiology*
-
Cognition Disorders / psychology
-
Cognition Disorders / rehabilitation*
-
Cognitive Behavioral Therapy*
-
Comorbidity
-
Cross-Sectional Studies
-
Decision Making*
-
Executive Function
-
Female
-
Humans
-
Impulsive Behavior / epidemiology*
-
Impulsive Behavior / psychology
-
Impulsive Behavior / rehabilitation*
-
Male
-
Mass Screening
-
Memory, Short-Term
-
Middle Aged
-
National Institute on Drug Abuse (U.S.)
-
Neuropsychological Tests / statistics & numerical data
-
Psychometrics
-
Reversal Learning
-
Set, Psychology
-
United States
-
Verbal Learning
-
Young Adult
Substances
-
Central Nervous System Stimulants